Found: 15
Select item for more details and to access through your institution.
Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A multicenter prospective study on efficacy and safety of imatinib generics: A report from Polish Adult Leukemia Group imatinib generics registry.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. E125, doi. 10.1002/ajh.24748
- By:
- Publication type:
- Article
Validation of HER2 Status in Whole Genome Sequencing Data of Breast Cancers with the Ploidy-Corrected Copy Number Approach.
- Published in:
- Molecular Diagnosis & Therapy, 2022, v. 26, n. 1, p. 105, doi. 10.1007/s40291-021-00571-1
- By:
- Publication type:
- Article
Bortezomib has little ex vivo activity in chronic myeloid leukemia: individual tumor response testing comparative study in acute and chronic myeloid leukemia.
- Published in:
- Contemporary Oncology / Współczesna Onkologia, 2012, v. 16, n. 3, p. 210, doi. 10.5114/wo.2012.29286
- By:
- Publication type:
- Article
Esterase D and gamma 1 actin level might predict results of induction therapy in patients with acute myeloid leukemia without and with maturation.
- Published in:
- Medical Oncology, 2013, v. 30, n. 4, p. 1, doi. 10.1007/s12032-013-0725-2
- By:
- Publication type:
- Article
Germline missense NF1 mutation in an elderly patient with a blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Plasma concentration of humoral factors in patients with chronic myeloid leukemia and early molecular response.
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 81
- By:
- Publication type:
- Article
Additional chromosomal abnormality profiles analysis allowed to identify CML patients responding optimally to TKI treatment.
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 37
- By:
- Publication type:
- Article
Limfocytoza CD4+CD8+ oraz wysięki osierdziowy i opłucnowy u chorego na przewlekłą białaczkę szpikową w fazie przewlekłej leczonego dazatynibem z powodu niepowodzenia terapii imatynibem.
- Published in:
- Hematology (2081-0768), 2015, v. 6, n. 3, p. 301, doi. 10.5603/Hem.2015.0041
- By:
- Publication type:
- Article
Głęboka odpowiedź molekularna po podaniu dazatynibu w 3. linii terapii u chorego na przewlekłą białaczkę szpikową w fazie przewlekłej.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Prognostic Impact of Copy Number Alterations' Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5431, doi. 10.3390/cancers15225431
- By:
- Publication type:
- Article
The Depth of the Molecular Response in Patients with Chronic Myeloid Leukemia Correlates with Changes in Humoral Immunity.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 8, p. 2353, doi. 10.3390/jcm13082353
- By:
- Publication type:
- Article
Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways.
- Published in:
- OncoTargets & Therapy, 2022, v. 15, p. 1123, doi. 10.2147/OTT.S371847
- By:
- Publication type:
- Article
B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib.
- Published in:
- Case Reports in Medicine, 2016, p. 1, doi. 10.1155/2016/9806515
- By:
- Publication type:
- Article
Essential thrombocythaemia progression to the fibrotic phase is associated with a decrease in JAK2 and PDL1 levels.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 12, p. 2665, doi. 10.1007/s00277-022-05001-8
- By:
- Publication type:
- Article